Molecular Subgroups of Glioblastoma– an Assessment by Immunohistochemical Markers

IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced

(2017) Huixia Zhu et al.   PLoS One

PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma

(2017) Balázs Murnyák et al.   Oncotarget

Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology

(2017) Oliver Eidel et al.   PLoS One

A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples

(2017) Anna Esteve-Codina et al.   PLoS One

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis

(2016) Chiara Bardella et al.   CANCER CELL

Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence

(2016) Tamás Csonka et al.   FOLIA NEUROPATHOLOGICA

Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival

(2016) Ajay Chaurasia et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Dairy Product, Calcium Intake and Lung Cancer Risk: A Systematic Review with Meta-Analysis

(2016) Yang Yang et al.   Scientific Reports

Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition

(2016) Anna Segerman et al.   Cell Reports

Clinical and molecular cytogenetic analyses of four patients with imbalanced translocations

(2016) Hong Yan Liu et al.   Molecular Cytogenetics

Mitochondrial energy metabolism and apoptosis regulation in glioblastoma

(2015) Adam Nagy et al.   BRAIN RESEARCH

Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma

(2015) Long Chen et al.   HUMAN PATHOLOGY

Clinicopathologic implications of NF1 gene alterations in diffuse gliomas

(2015) M. Adelita Vizcaíno et al.   HUMAN PATHOLOGY

Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme

(2015) Takuma Kawasoe et al.   JOURNAL OF NEUROSURGERY

Comprehensive genomic characterization of head and neck squamous cell carcinomas

(2015)   NATURE

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects

(2015) Yong-Chang Liu et al.   TUMOR BIOLOGY

Molecular heterogeneity of glioblastomas: does location matter?

(2015) Emilie Denicolaï et al.   Oncotarget

From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity

(2015) Marc Aubry et al.   Oncotarget

Original article Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas

(2014) Tamás Csonka et al.   FOLIA NEUROPATHOLOGICA

Immunohistochemical Classification of Primary and Secondary Glioblastomas

(2014) Kyu Sang Lee et al.   Korean Journal of Pathology

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach

(2014) Siobhan Conroy et al.   PLoS One

Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status

(2014) Jae Kyung Myung et al.   Translational Oncology

Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes

(2013) Daniel Stieber et al.   ACTA NEUROPATHOLOGICA

The Somatic Genomic Landscape of Glioblastoma

(2013) Cameron W. Brennan et al.   CELL

Using the molecular classification of glioblastoma to inform personalized treatment

(2013) Adriana Olar et al.   JOURNAL OF PATHOLOGY

Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma

(2013) B. Kalman et al.   NEUROMOLECULAR MEDICINE

High Frequency of Temperature-Sensitive Mutants of p53 in Glioblastoma

(2013) Jana Smardova et al.   PATHOLOGY & ONCOLOGY RESEARCH

Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme

(2013) Bryant England et al.   TUMOR BIOLOGY

Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants

(2012) Nancy M Joseph et al.   MODERN PATHOLOGY

Cord Blood Stem Cells Inhibit Epidermal Growth Factor Receptor Translocation to Mitochondria in Glioblastoma

(2012) Venkata Ramesh Dasari et al.   PLoS One

A Simplified Approach for the Molecular Classification of Glioblastomas

(2012) Marie Le Mercier et al.   PLoS One

A multigene predictor of outcome in glioblastoma

(2011) H. Colman et al.   NEURO-ONCOLOGY

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

(2010) Houtan Noushmehr et al.   CANCER CELL

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples

(2010) Prashanth Setty et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile

(2010) Concha Lopez-Gines et al.   MODERN PATHOLOGY

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE